114 related articles for article (PubMed ID: 12948370)
1. Antibodies against mumps in The Netherlands as assessed by indirect ELISA and virus neutralization assay.
van den Hof S; Beaumont MT; Berbers GA; de Melker HE
Epidemiol Infect; 2003 Aug; 131(1):703-9. PubMed ID: 12948370
[TBL] [Abstract][Full Text] [Related]
2. Determination of vaccine-induced and naturally acquired class-specific mumps antibodies by two indirect enzyme-linked immunosorbent assays.
Nigro G; Nanni F; Midulla M
J Virol Methods; 1986 May; 13(2):91-106. PubMed ID: 3016017
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological standardization of a test for susceptibility to mumps.
Shehab ZM; Brunell PA; Cobb E
J Infect Dis; 1984 May; 149(5):810-2. PubMed ID: 6373967
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization.
Avijgan M; Habibian R; Kheiri S
East Mediterr Health J; 2009; 15(2):295-301. PubMed ID: 19554975
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks.
Smits G; Mollema L; Hahné S; de Melker H; Tcherniaeva I; Waaijenborg S; van Binnendijk R; van der Klis F; Berbers G
PLoS One; 2013; 8(3):e58234. PubMed ID: 23520497
[TBL] [Abstract][Full Text] [Related]
6. Humoral immunity to mumps in a highly vaccinated population in Taiwan.
Ho YH; Tsai CC; Tsai YW; Wang YC; Lin TY; Lee DJ; Chen CJ
J Microbiol Immunol Infect; 2019 Jun; 52(3):379-385. PubMed ID: 29046249
[TBL] [Abstract][Full Text] [Related]
7. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assay compared with neutralization tests for evaluation of live mumps vaccines.
Sakata H; Hishiyama M; Sugiura A
J Clin Microbiol; 1984 Jan; 19(1):21-5. PubMed ID: 6361060
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay of mumps antibody for evaluation of immune status before and after vaccination.
Kuno-Sakai H; Iwasaki H; Kimura M
J Infect Dis; 1984 May; 149(5):813. PubMed ID: 6726005
[No Abstract] [Full Text] [Related]
10. Detection of postvaccination mumps virus antibody by neutralization test, enzyme-linked immunosorbent assay and sensitive hemagglutination inhibition test.
Fedová D; Brůcková M; Plesník V; Slonim D; Sejda J; Svandová E; Kubínová I
J Hyg Epidemiol Microbiol Immunol; 1987; 31(4):409-22. PubMed ID: 3429853
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
Mossong J; Putz L; Schneider F
Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of mumps before the introduction of mumps-containing vaccine in Lao PDR: results from a nationwide cross-sectional population-based survey.
Okabayashi H; Komada K; Kidokoro M; Kitamura T; Miyano S; Ito T; Phounphenghak K; Pathammavong C; Murano K; Nagai M; Mori Y; Komase K; Xeuatvongsa A; Takeda M; Hachiya M
BMC Res Notes; 2019 Mar; 12(1):155. PubMed ID: 30890154
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps.
Harmsen T; Jongerius MC; van der Zwan CW; Plantinga AD; Kraaijeveld CA; Berbers GA
J Clin Microbiol; 1992 Aug; 30(8):2139-44. PubMed ID: 1500523
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of the serologic response in vaccinated and unvaccinated mumps cases during an epidemic.
Kaaijk P; Gouma S; Hulscher HI; Han WG; Kleijne DE; van Binnendijk RS; van Els CA
Hum Vaccin Immunother; 2015; 11(7):1754-61. PubMed ID: 26047038
[TBL] [Abstract][Full Text] [Related]
15. [Contribution of the detection of IgA antibodies to the laboratory diagnosis of mumps in the population with a high vaccination coverage].
Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Malý M
Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):16-9. PubMed ID: 25872991
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of mumps, varicella and rubella antibodies in children 1-16 years of age in eastern Turkey.
Gürgöze MK; Yilmaz E; Gödekmerdan A; Akça Z; Doğan Y; Akarsu S; Aygün AD
Turk J Pediatr; 2006; 48(3):185-8. PubMed ID: 17172059
[TBL] [Abstract][Full Text] [Related]
17. Mumps in Poland since 1990 to 2003; epidemiology and antibody prevalence.
Janaszek-Seydlitz W; Bucholc B; Gorska P; Slusarczyk J
Vaccine; 2005 Apr; 23(21):2711-6. PubMed ID: 15780717
[TBL] [Abstract][Full Text] [Related]
18. Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralisation assay.
van den Hof S; van Gageldonk-Lafeber AB; van Binnendijk RS; van Gageldonk PG; Berbers GA
Vaccine; 2003 Oct; 21(27-30):4210-4. PubMed ID: 14505900
[TBL] [Abstract][Full Text] [Related]
19. The 2001 serological survey in the Czech Republic--mumps.
Mrázová M; Smelhausová M; Sestáková Z; Svandová E; Benes C
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S50-3. PubMed ID: 15080260
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
Glikmann G; Petersen I; Mordhorst CH
Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
